Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 10/31/2023 | 96,288,553 | Total gross of voting rights: 96,288,553 |
| Total net* of voting rights: 96,084,083 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$0.73 |
| Daily Change: | -0.03 -4.01 |
| Daily Volume: | 41,206 |
| Market Cap: | US$70.230M |
November 06, 2024 October 22, 2024 September 23, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
